Lombardo Doing the Bidding of Billionaires, Special Interests as Nevadans Drown in Sky-High Health Care and Housing Costs 

The Nevadan: Lombardo’s pharmaceutical industry donations surged after he vetoed bills that would have lowered drug costs for chronic and deadly illnesses.

Joe Lombardo could have lowered housing and prescription drug costs for all Nevadans, but instead, he remains beholden to his billionaire backers —- blocking groundbreaking legislation all while taking millions from corporate real estate and pharmaceutical interests.

A new distressing report from the New York Times on the growing influence of billionaires in our elections detailed how, after real estate mogul Robert Bigelow bankrolled Lombardo’s candidacy with tens of millions of dollars, the governor vetoed legislation to lower housing costs, protect renters, and prevent Wall Street firms from pricing Nevadans out of purchasing a home. While Lombardo continues to put wealthy special interests over everyday Nevadans, a recent survey found that under Lombardo, an overwhelming majority of Nevadans think housing is unaffordable — and they’re right.

Another new report also revealed how, as Nevadans’ health care costs continue to rise faster than anywhere else in the nation, Lombardo has raked in hundreds of thousands of dollars more in Big Pharma cash after vetoing bills that would have reduced prescription drug costs by lowering them to the Medicare-negotiated rates for all Nevadans.

See coverage below:

New York Times: The Scale of Billionaires’ Campaign Donations is Overwhelming U.S. Politics

  • In 2022, Robert Bigelow, the ultrawealthy owner of the extended-stay hotel chain Budget Suites of America, threw his weight behind Joe Lombardo, a Republican running for governor of Nevada.

  • His support included some $12.3 million sent to a series of political action committees that heavily backed Mr. Lombardo, along with many donations sent in $10,000 increments from various business entities linked to Mr. Bigelow — each one the maximum allowed during an election cycle in the state.

  • The next year, Democratic lawmakers passed bills to expand tenant protections and limit evictions. It was a key issue for Mr. Bigelow, who had spoken out vigorously against a federal moratorium on evictions imposed during the coronavirus pandemic, calling it “legalized theft.”

  • Mr. Lombardo vetoed the measures, citing in part the burdens on landlords. Last year, he vetoed another round of similar legislation. Along the way, according to documents released under public records law, Mr. Lombardo has made time to dine with Mr. Bigelow, including a private meeting in the spring of 2024 at DragonRidge Country Club.

The Nevadan-El Nevadense: Lombardo vetoes benefiting drug companies draw suspicion

  • Records also show [Lombardo] vetoed health care bills that the industry opposed.

  • Considine sponsored AB250 in 2023 and AB259 in 2025, both of which passed a Democrat-controlled state Legislature with each Republican voting no. The policies mirrored provisions of then-President Joe Biden’s 2022 Inflation Reduction Act, which allowed the government to negotiate the prices of the “highest use, most expensive and most life-saving drugs for Medicare,” she said.

  • Her proposals—which were vetoed by the governor—would have opened the door for Nevada to do the same thing, but for all Nevadans statewide, not just those on federal support. Considine said the policies would have reined in prescription drug prices for chronic illnesses such as blood cancer, diabetes, and rheumatoid arthritis, restricting places and providers from charging more than the Medicare-negotiated price.

  • According to the Centers for Disease Control and Prevention, heart and chronic liver disease, cancer, and diabetes are leading causes of death in Nevada.

  • Lombardo’s fundraising efforts surged with pharmaceutical dollars following his health care vetoes. Donors representing pharmaceutical companies that manufacture various medicines, including those for liver and kidney diseases, as well as for chronic illnesses such as HIV, flocked to his campaign and dark money groups after the 2023 legislative session.

  • Just months after Lombardo rejected AB250 in the summer of 2023, his campaign and PACs received $80,000 from pharmaceutical companies.

  • In the fundraising period after Lombardo’s veto of AB259, he received more than $28,000 in direct contributions from pharmaceutical companies to his second term campaign. Meanwhile, his Nevada Way PAC amassed more than $101,000 from Big Pharma during that same time frame.
  • These large fundraising hauls stand in stark contrast to his initial fundraising results, which yielded only $7,500 from pharmaceutical interests. Democrats accused Lombardo of putting drug companies over Nevada families.

###

SHARE

Chip in now to Keep Nevada Blue

*If you've saved your information with ActBlue Express, your donation will go through immediately.

Chip in to elect Nevada Democrats!

Click on an amount to get started. If you’ve saved your payment information with ActBlue Express, your donation will go through immediately.**